ALLYSON STANTON: Open Payments
NPI 1518992684 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 37 payments from 13 companies in 2025. Trend: 2023 $693 · 2024 $563 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $191 |
| Fresenius USA Marketing, Inc. | 9 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $133 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Travere Therapeutics, Inc. | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $35 |
| Novo Nordisk Inc | 2 | $30 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Ardelyx, Inc. | 1 | $20 |
Products named: JARDIANCE, VELPHORO, KRYSTEXXA, TAVNEOS, JYNARQUE, ACTHAR, Wegovy, FUROSCIX.
Industry payments across NC — which companies pay providers there.
